logo
  

Novavax To Participate In Oxford University Study Comparing Mixed COVID-19 Vaccine

Novavax Inc. (NVAX) said Thursday that it will participate in a newly expanded Phase 2 clinical trial called "Comparing COVID-19 Vaccine Schedule Combinations - Stage 3" or Com-COV3. The study will be led by the University of Oxford and funded by the UK Vaccines Taskforce or VTF and the National Institute for Health Research or NIHR.

Novavax' recombinant nanoparticle COVID-19 vaccine candidate, NVX-CoV2373, is one of the three COVID-19 vaccines that will be studied in adolescents to evaluate the potential for combined regimens that mix vaccines from different manufacturers to achieve immune protection against COVID-19.

The clinical trial will include at least 360 adolescents 12-16 years of age. Volunteers will receive an authorized vaccine as a first dose and then at least 8 weeks later will receive one of three different vaccines as a second dose.

The company noted that all participants will be randomly allocated at the time of the second dose to receive either a full dose or half dose of the same vaccine given for the first dose, a full dose of the Novavax vaccine or a half dose of a different authorized vaccine.

The research will compare the immune system responses from those who receive a heterologous regimen to those who receive a homologous regimen.

Under the protocol, participants will be followed for safety and immune responses. Results from the study are expected within a few months.

The company stated that the UK Medicines and Healthcare products Regulatory Agency and Joint Committee on Vaccination and Immunisation will formally assess the safety and efficacy of any new vaccination process before advising whether it is rolled out.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ontario, Canada-based Erie Meat Products Ltd. is recalling approximately 1,224 pounds of fully cooked chicken bologna products, according to the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS. The chicken bologna products were imported and distributed into the United States without the benefit of FSIS import reinspection. The U. S. Food and Drug Administration or FDA has issued a public health alert against Fulvic Care Powder and Tablets from Ontario, Canada -based Black Oxygen Organics due to elevated levels of lead and arsenic. The agency advised consumers not to use Fulvic Care Powder and Tablets from Black Oxygen or give the products to pets due to elevated levels of lead and arsenic. Alexander & Hornung, a business unit of Perdue Premium Meat Co., Inc., is recalling around 234,391 pounds of fully cooked pork products citing possible contamination with Listeria monocytogenes, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves ham and pepperoni products that come under various brands and produced on various dates.
Follow RTT